Introduction {#sec1}
============

Nearly all of the photoactive iridium(III) complexes that are used as emitters in electroluminescent devices,^[@ref1]−[@ref6]^ as dyes in solar cells,^[@ref7]−[@ref9]^ in nonlinear optics (NLO),^[@ref10]−[@ref12]^ as photoredox catalysts,^[@ref13],[@ref14]^ as solar fuels,^[@ref15]^ and in bioimaging^[@ref16],[@ref17]^ contain conjugated five-membered chelated ligands, such as the commonly used 2-phenylpyridine (ppyH), 2,2′-bipyridine (bpy), acetylacetonate (acac), and picolinate (pic). Photoactive iridium complexes containing a *six*-membered cyclometalating chelate are very rare, and the few reported examples can be categorized into two families of complexes: those containing conjugated^[@ref18]−[@ref21]^ or nonconjugated^[@ref22]−[@ref24]^ bidentate cyclometalating ligands. For instance, in 2008, Song et al.^[@ref22]^ obtained a phosphorescent Ir(III) complex \[Ir(dfb-pz)~2~(fptz)\] (where (dfb-pz)H = 2,4-difluorobenzyl-N-pyrazole and fptz = 3-trifluoromethyl-5-(2-pyridyl)triazole) containing a nonconjugated *N*-benzylpyrazole ligand to form a six-membered chelated framework. This complex is a blue emitter in dichloromethane with λ~em~ = 437 and 460 nm (Φ~PL~ = 10% and τ~e~ = 0.10 μs). The methylene spacer of the cyclometalated ligand effectively interrupts the π-conjugation to produce a significant blue shift, compared to \[Ir(dFppy)~2~(fptz)\] (where dFppyH = 2-(2,4-difluorophenyl)pyridine, which uses a five-membered ring chelate C\^N ligand and the same ancillary ligand (λ~em~ = 460 and 489 nm in dichloromethane).^[@ref25]^ By contrast, Zhu et al.^[@ref18]^ reported in 2005 the iridium(III) complex \[Ir(bis\[2-(*N*-carbazolyl)pyridinato-*N*,*C*^3′^)picolinate\] (\[Ir(cpy)~2~(pic)\]) containing a six-membered chelating framework where the ligand is fully conjugated, leading to yellow luminescence in the recrystallized solid state with λ~em~ = 538 nm (Φ~PL~ = 5%).

In an ongoing effort in our group to develop charged blue-emitting phosphors for solution-processed light-emitting electrochemical cells (LEECs) and organic light emitting diodes (OLEDs), we investigated the coordination of 2-benzhydrylpyridine (bnpyH~2~) derivatives with Ir(III) in order to access six-membered chelate complexes **T1**--**T3** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a). Surprisingly, given the prior art, upon sequential treatment of IrCl~3~·6H~2~O with bnpyH~2~ and then 4,4′-di-*tert-*butyl-2,2′-bipyridine (d*t*Bubpy) in a one-pot reaction,^[@ref26]^**T1** was not obtained. Instead, neutral complex \[Ir(bnpy)(d*t*Bubpy)Cl\], **1**, was isolated. The formation of **1** arises from a highly unusual double C--H bond activation^[@ref27]^ of the bnpyH~2~ ligand, which binds to the iridium in a tripodal fashion. Following a similar synthetic protocol, analogues **2** and **3**, functionalized with either electron-donating *tert*-butyl or electron-withdrawing trifluoromethyl groups *meta* to the Ir--C bonds, were obtained. To the best of our knowledge, this is the first report of an iridium complex of the form \[Ir(C\^N\^C)(N\^N)Cl\] and one in which the tridentate bis-cyclometalated ligand is a tripod featuring two six-membered metallacycles.^[@ref28]^ Indeed, the complex with the closest binding motif is \[Ir(bppy)(bpy)Cl\],^[@ref29]^ where bppy is 2-(\[1,1′-biphenyl\]-3-yl)pyridine. This previous complex possesses a related \[Ir(C\^C\^N)(N\^N)Cl\] structure, but the bppy ligand coordinates to the iridium in the more commonly observed planar five-membered chelate fashion. It is a very poorly luminescent near-IR emitter in CH~2~Cl~2~ (λ~em~ = 725 nm, Φ~PL~ = 8.4 × 10^--2^%). Ir(III) complexes bearing monocyclometalating planar tridentate bis(five-membered) chelate ligands (e.g., N\^N\^C^[@ref29]^ or N\^C\^N^[@ref30]−[@ref35]^) and a cyclometalating bidentate ligand, C\^N, have on the other hand been more widely explored, while Kozhevnikov has reported dinuclear Ir(III) complexes with a bridging ligand featuring two N\^C\^N motifs.^[@ref36],[@ref37]^

![(a) Scheme for the proposed synthesis of the initial targets (**T1**--**T3**) and the synthesis of complexes **1**--**3**. (*a*, i) IrCl~3~·6H~2~O, 2-ethoxyethanol/H~2~O (3:1), reflux, 19 h; (ii) d*t*Bubpy, reflux, 6 h. (*b*) aq. NH~4~PF~6~. (b) Solid-state structures of **1**--**3**. Thermal ellipsoids correspond to a 50% probability level. Solvent molecules are omitted for clarity.](ic-2017-00328t_0006){#fig1}

Results and Discussion {#sec2}
======================

Synthesis {#sec2.1}
---------

Compounds **L1**, **L2**, and **L3** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) were synthesized in two steps via a Grignard reaction^[@ref38]^ followed by a reduction step^[@ref38]^ and obtained as solids in good yields. A mixture of the corresponding proligand and IrCl~3~·6H~2~O in 2-ethoxyethanol/H~2~O (3:1) was refluxed. After 19 h, d*t*Bubpy 4,4′-di-*tert*-butyl-2,2′-bipyridyl was added at once, and heating was continued for 6 h to give the neutral complexes **1**--**3** as solids in a one-pot synthesis^[@ref26]^ in 45%, 51%, and 55% yield, respectively ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a). Complexes **1**--**3** were characterized by ^1^H, ^13^C, and, for **3**, ^19^F NMR spectroscopy; ESI-HR mass spectra; elemental analysis; and melting point determination (see Figures **S21**--**S30** in the [Supporting Information](#notes-1){ref-type="notes"} (SI) for NMR and ESI-HR mass spectra).

![Synthesis of Intermediates **A1**--**A3** and Target Ligands **L1**--**L3**\
(a, 1) Mg, 1,2-dibromoethane, THF, N~2~, reflux, 4 h. (2) Methyl picolinate, THF, 0 °C to r.t., 90 min; (b, 1) HOAc, 57% HI. (2) NaOH~aq~., 0 °C to r.t.; (c, 1) PBr~3~, reflux, 2 h. (2) Zn, HOAc, (3) NaOH~aq~., 0 °C to r.t.](ic-2017-00328t_0004){#sch1}

Crystal Structures {#sec2.2}
------------------

Single crystals of sufficient quality of **1**--**3** were grown from CH~2~Cl~2~/Et~2~O at −18 °C. The structures of **1**--**3** were determined by single-crystal X-ray diffraction ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b, [Table S1](#notes-1){ref-type="notes"}).^[@ref39]^ All three complexes possess a distorted octahedral geometry with the tridentate tripod ligand coordinated to the iridium to form two six-membered chelated rings. Both cyclometalating carbon atoms are *trans* to the pyridine rings of the d*t*Bubpy, and the pyridyl unit of the bnpy-type ligands is *trans* to the chloride. This contrasts with the configuration of the Ir--Cl bond in previously reported Ir(III) complexes,^[@ref29],[@ref31],[@ref32],[@ref36],[@ref37],[@ref40],[@ref41]^ where an Ir--C bond is *trans* to the chloride ligand. For **1**--**3**, the Ir--Cl bond \[2.375(3) Å for **1**, 2.3612(8) Å for **2**, and 2.369(2) Å for **3**\] is in the same range as that found for \[Ir(tpy)(dmbpy)Cl\]^2+^ (2.357 Å, where tpy = 2,2′:6′,2″-terpyridine and dmbpy = 4,4′-dimethyl-2,2′-bipyridine)^[@ref42]^ but is significantly shorter (by ca. 0.1 Å) than the Ir--Cl bond in other cyclometalated tridentate Ir(III) complexes.^[@ref29],[@ref31],[@ref32],[@ref36],[@ref37],[@ref40],[@ref41]^ Given the short Ir--C~C\^N\^C~ bonds \[2.048(13) and 2.064(6) Å for **1**, 2.028(4) and 2.031(3) Å for **2**, and 2.017(7) and 2.027 Å for **3**\], this leads also to a correspondingly shorter Ir--N~C\^N\^C~ bond \[2.055(11) Å for **1**, 2.044(3) for **2**, and 2.032(7) Å for **3**\] compared to the Ir--N~d*t*Bubpy~ bonds \[2.158(10) and 2.159(11) Å for **1**, 2.127(3) and 2.140(3) Å for **2**, and 2.122(6) and 2.133(5) Å for **3**\]. The bite angle of the N\^N ligand is unremarkable at 75.60(4)° for **1**, 75.85(12)° for **2**, and 76.1(2)° for **3** and in line with cationic Ir(III) complexes of the form \[Ir(C\^N)~2~(N\^N)\]^+^.^[@ref43]−[@ref47]^ Owing to the presence of the six-membered chelates, the C--Ir--C bond angle is significantly larger (85.60(5)° for **1**, 85.65(15)° for **2**, and 84.(3) for **3**) than the N~d*t*Bubpy~--Ir--N~d*t*Bubpy~ bond angle.

Electrochemical Properties {#sec2.3}
--------------------------

The electrochemical behavior for **1**--**3** was evaluated by cyclic voltammetry (CV) and differential pulse voltammetry (DPV) in deaerated CH~2~Cl~2~ solution at 298 K at a scan rate of 50 mV s^--1^ using Fc/Fc^+^ as the internal reference and referenced with respect to SCE.^[@ref48]^ The electrochemistry data can be found in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, and the voltammograms are shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. All complexes exhibit a quasi-reversible single electron oxidation peak, which is attributed to the Ir(III)/Ir(IV) redox couple with contributions from the bnpy-type ligand. Complex **2** displays a lower oxidation potential (0.80 V) than **1** (0.87 V), both of which are notably lower than \[Ir(mesppy)~2~(d*t*Bubpy)\]PF~6~ (*E*~1/2;ox.~ = 1.17 V in deaerated CH~2~Cl~2~, where mesppy is 2-phenyl-4-mesityl-pyridinato).^[@ref49]^ Conversely, **3** shows a significantly anodically shifted oxidation potential at 1.14 V. The CVs of **1**--**3** show irreversible reduction waves that are monoelectronic as inferred from the respective DPVs. DFT calculations ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a) indicate that both the HOMO and HOMO--1, which are close in energy (see Figure S34 in the [SI](#notes-1){ref-type="notes"}), involve the iridium and chloride atoms and the two phenyl rings of the bnpy ligand. The LUMO is almost exclusively localized on the d*t*Bubpy ligand, while the LUMO+1 is primarily on the pyridyl ring of the bnpy ligand. Therefore, we conclude that the reduction is based on the ancillary ligand. The reduction potentials of **1** and **2** are each found at −1.82 V, while the reduction wave of **3** at −1.62 V is anodically shifted by 200 mV compared to **1** and **2**. All three complexes are significantly more difficult to reduce than \[Ir(mesppy)~2~(d*t*Bubpy)\]PF~6~ (*E*~1/2;red.~ = −1.15 V), which also shows an irreversible reduction in CH~2~Cl~2~.^[@ref49]^

![Cyclic voltammograms (in solid lines) and differential pulse voltammetry (in dotted lines) carried out in degassed CH~2~Cl~2~ at a scan rate of 50 mV s^--1^, with Fc/Fc^+^ as the internal reference, referenced to SCE (0.46 V vs SCE).^[@ref48]^](ic-2017-00328t_0001){#fig2}

![(a) Representation of the four frontier MOs of **1**. (b) Side and top views of the spin density distribution for the lowest triplet state (T~1~) of **1**.](ic-2017-00328t_0002){#fig3}

###### Luminescent and Electrochemical Properties of Complexes **1**--**3**

          λ~em~[a](#t1fn1){ref-type="table-fn"} \[nm\]   Φ~PL~[a](#t1fn1){ref-type="table-fn"},[b](#t1fn2){ref-type="table-fn"} \[%\]   τ~e~[c](#t1fn3){ref-type="table-fn"} \[ns\]   *k*~r~[d](#t1fn4){ref-type="table-fn"} × 10^--5^ \[s^--1^\]   *k*~nr~[e](#t1fn5){ref-type="table-fn"} × 10^--5^ \[s^--1^\]   *E*~pa~[f](#t1fn6){ref-type="table-fn"} \[V\]   *E*~pc~[f](#t1fn6){ref-type="table-fn"} \[V\]
  ------- ---------------------------------------------- ------------------------------------------------------------------------------ --------------------------------------------- ------------------------------------------------------------- -------------------------------------------------------------- ----------------------------------------------- -----------------------------------------------
  **1**   619                                            8                                                                              318                                           2.52                                                          28.93                                                          0.87                                            --1.82
  **2**   630                                            6                                                                              239                                           2.51                                                          39.33                                                          0.80                                            --1.81
  **3**   581                                            26                                                                             718                                           3.62                                                          10.31                                                          1.14                                            --1.62

λ~exc~ = 420 nm, recorded at 298 K in deaerated CH~2~Cl~2~ solution.

\[Ru(bpy)~3~\]PF~6~ in MeCN as reference (Φ~PL~ = 1.8% in aerated MeCN at 298 K).^[@ref51]^

λ~exc~ = 378 nm.

*k*~r~ = Φ~PL~/τ~e~.

*k*~nr~ = \[(1 -- Φ~PL~)/τ~e~\].

Measurements were carried out in degassed CH~2~Cl~2~ at a scan rate of 50 mV s^--1^ with Fc/Fc^+^ used as the internal reference, and referenced with respect to SCE (Fc/Fc^+^ = 0.46 V in CH~2~Cl~2~).^[@ref48]^

Photophysical Properties {#sec2.4}
------------------------

The normalized UV--vis absorption spectra of **1**--**3** recorded in CH~2~Cl~2~ at 298 K are depicted in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} and the data summarized in Table S2 in the [SI](#notes-1){ref-type="notes"}. All complexes show similar absorption profiles. The invariance of the intense high-energy (ε on the order of (1--1.5) × 10^4^ M^--1^ cm^--1^) absorption bands below 300 nm are ascribed to ^1^π--π\* ligand-centered (^1^LC) transitions localized on the d*t*Bubpy ligand. Two moderately intense bands (ε on the order of (3--5) × 10^3^ M^--1^ cm^--1^) in the region of 340--360 nm and 390--405 nm are assigned to mixed charge-transfer transitions with the former consisting of more metal-to-ligand/ligand-to-ligand charge-transfer (^1^MLCT/^1^LLCT) character while the latter, according to TD-DFT calculations, implicate an intraligand CT (^1^ILCT) from the phenyl rings to the pyridyl heterocycle of the bnpy-type ligand (see Figure S34 and Table S3 in the [SI](#notes-1){ref-type="notes"}). Weak bands (ε on the order of 10^3^ M^--1^ cm^--1^) with onsets between 470 and 510 nm and tailing to 580 nm are attributed to a mixture of ^1^MLCT/^1^LLCT and spin-forbidden ^3^MLCT/^3^LLCT transitions involving the d*t*Bubpy ligand. Introduction of the *tert*-butyl groups in **2** results in a small red-shift of the CT bands below 340 nm, whereas the trifluoromethyl groups in **3** produce a significant blue-shift of these bands, trends that are corroborated by TD-DFT calculations (Figure S35 in the [SI](#notes-1){ref-type="notes"}).

![Normalized UV--vis absorption and photoluminescence spectra of **1**--**3** in CH~2~Cl~2~ at 298 K.](ic-2017-00328t_0003){#fig4}

The normalized photoluminescence (PL) spectra of **1**--**3** in degassed CH~2~Cl~2~ are shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}, and the data are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Upon photoexcitation at 420 nm, all complexes show a broad and unstructured profile, indicative of an emission with mixed CT character. In line with the trends observed in the absorption spectra and the oxidation potentials in the CVs, the emission maxima are 581, 619, and 630 nm for **3**, **1**, and **2**, respectively. These emission maxima match very closely to the vertical phosphorescence energies calculated by spin-unrestricted DFT, which predicts emissions at 573, 613, and 622 nm, respectively. The calculations reveal that the emissive triplet state is localized on the iridium, chlorine, and d*t*Bubpy but does not include significant contributions from the bnpy ligand ([Figures [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b and S36 in the [SI](#notes-1){ref-type="notes"}). The photoluminescence quantum yield (Φ~PL~) of **1** is 8%, which is lower than that of the yellow-emitting \[Ir(ppy)~2~(d*t*Bubpy)\]PF~6~ (Φ~PL~ = 64% in CH~2~Cl~2~, λ~em~ = 570 nm, where ppyH is 2-phenylpyridine).^[@ref50]^ The Φ~PL~ of **2** is 6% while that of **3** is 26%. All three complexes show emission lifetimes, τ~e~, in the submicrosecond regime. The radiative rate constants, *k*~r~, for **1** and **2** are similar (2.52 vs 2.51 × 10^5^ s^--1^, respectively). However, **2** exhibits a significantly larger nonradiative rate constant, *k*~nr~ (39.33 × 10^5^ s^--1^), compared to **1** (28.93 × 10^5^ s^--1^). Complex **3** possesses both the largest *k*~r~ (3.62 × 10^5^ s^--1^) and the smallest *k*~nr~ values (10.31 × 10^5^ s^--1^) in accordance with the energy gap law.

Conclusions {#sec3}
===========

In conclusion, a new family of luminescent iridium(III) complexes bearing an unprecedented tripodal bis(six-membered) chelate tridentate ligand has been prepared through a highly unusual double cyclometalation reaction. The emission can be tuned through substitution on the cyclometalating aryl rings. DFT calculations support a mixed charge-transfer emission. Current efforts are focused on further modulating the electronics through a combination of modifications of the ancillary di-imine and the monodentate chloride ligands. This unprecedented tripodal ligand opens new perspectives for the design of tridentate Ir luminophores.

Experimental Section {#sec4}
====================

General Procedure for Compound **A1**--**A3** {#sec4.1}
---------------------------------------------

An oven-dried flask was charged under a nitrogen atmosphere with magnesium turnings (0.911 g, 37.50 mmol, 5 equiv) and THF (80 mL) followed by 2 mL of 1,2-dibromoethane. After the observation of gas evolution, the corresponding bromo derivative (22.50 mmol, 3 equiv) in THF (40 mL) was added dropwise. The reaction mixture was heated under stirring and kept at reflux for 4 h, resulting in a color change of the solution to gray. The reaction mixture was then cooled in an ice bath, and a solution of methyl picolinate (7.50 mmol, 1.00 equiv) in THF (40 mL) was added carefully. The mixture turned dark gray--black. The solution was allowed to warm to room temperature and was stirred for 90 min. The reaction mixture was quenched with aqueous NH~4~Cl and extracted with Et~2~O. The combined organic layers were dried over MgSO~4~, and the solvent was evaporated, leaving a residue, which was purified over silica (10% EtOAc in petroleum ether as the solvent). The desired fractions were combined, and the solvent was evaporated, leaving the title compound.

### Diphenyl(pyridin-2-yl)methanol **A1** {#sec4.1.1}

Compound **A1** was prepared according to the general procedure and was obtained as a colorless solid (1.686 g, 6.45 mmol). Yield: 86%. R~f~: 0.51 (10% EtOAc in petroleum ether on silica). Mp: 103 °C. Litt.^[@ref52]^: 102--103 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.60 (d, *J* = 4.7 Hz, 1H), 7.64 (td, *J* = 7.8, 1.8 Hz, 1H), 7.40--7.21 (m, 11H), 7.12 (d, *J* = 7.9 Hz, 1H), 6.28 (s, 1H). ^13^C NMR (101 MHz, CDCl~3~): δ 163.2, 147.7, 146.1, 136.4, 128.1, 127.9, 127.3, 122.9, 122.3, 80.8. HR-MS (FTMS^+^) \[M + H\]^+^ Calculated (C~18~H~15~NOH): 262.1226. Found: 262.1226. CHN Calcd for C~18~H~15~NO: C, 82.73; H, 5.79; N, 5.36. Found: C, 82.68; H, 5.73; N, 5.41. The compound characterization is in agreement with that previously reported.^[@ref53]^

### Bis(4-(*tert*-butyl)phenyl)(pyridin-2-yl)methanol **A2** {#sec4.1.2}

Compound **A2** was prepared according to the general procedure and was obtained as a colorless solid (1.994 g, 5.34 mmol). Yield: 71%. R~f~: 0.39 (10% EtOAc in petroleum ether on silica). Mp: 156 °C. Litt.^[@ref54]^: 156 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.58 (d, *J* = 3.2 Hz, 1H), 7.67--7.60 (m, 1H), 7.33--7.28 (m, 4H), 7.24--7.12 (m, 6H), 6.19 (s, 1H), 1.30 (s, 18H). ^13^C NMR (101 MHz, CDCl~3~): δ 163.8, 150.1, 147.7, 143.3, 136.4, 127.9, 124.9, 123.1, 122.3, 80.6, 34.6, 31.5. HR-MS (FTMS^+^) \[M + H\]^+^ Calculated (C~26~H~31~NOH): 374.2478. Found: 374.2476. CHN Calcd for C~26~H~31~NO: C, 83.60; H, 8.37; N, 3.75. Found: C, 83.45; H, 8.51; N, 3.88. The compound characterization is in agreement with that previously reported.^[@ref54]^

### Pyridin-2-ylbis(4-(trifluoromethyl)phenyl)methanol **A3** {#sec4.1.3}

Compound **A3** was prepared according to the general procedure and was obtained as a beige solid (1.893 g, 4.76 mmol). Yield: 64%. R~f~: 0.26 (10% EtOAc in petroleum ether on silica). Mp: 164 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.64 (d, *J* = 7.4 Hz, 1H), 7.75--7.69 (m, 1H), 7.60 (s, 4H), 7.44 (s, 4H), 7.31 (d, *J* = 8.5 Hz, 1H), 7.13 (d, *J* = 9.7 Hz, 1H), 6.50 (s, 1H). ^13^C NMR (101 MHz, CDCl~3~): δ 161.5, 149.4, 148.2, 136.9, 130.4, 130.1, 129.7, 129.4, 128.5, 125.2, 125.1, 125.1, 125.1, 123.1, 122.7, 80.4, 77.4, 77.1, 76.7. ^19^F NMR (376 MHz, CDCl~3~): δ −62.59. HR-MS (FTMS^+^) \[M + H\]^+^ Calculated (C~20~H~13~F~6~NOH): 398.0974. Found: 398.0965. CHN Calcd for C~20~H~13~F~6~NO: C, 60.46; H, 3.30; N, 3.53. Found: C, 60.51; H, 3.36; N, 3.59.

### 2-Benzhydrylpyridine **L1** {#sec4.1.4}

A mixture of **A1** (0.837 g, 3.21 mmol), aqueous 57% HI (2.5 mL), and HOAc (13 mL) was heated to 100 °C for 4 h. The resulting mixture was then cooled to 0 °C and basified to pH 9 with an aqueous NaOH solution (2 M). Ethyl acetate (100 mL) was added, and the mixture was washed successively with an aqueous NaHSO~3~ solution and brine. The combined organic layers were dried over MgSO~4~, and the solvent was evaporated. The residue was purified over silica (10% EtOAc in petroleum ether as the solvent). The desired fractions were combined and the solvent evaporated leaving a beige solid (0.788 g, 3.21 mmol). Yield: 74%. R~f~: 0.3 (10% EtOAc in petroleum ether on silica). Mp: 95 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.64 (d, *J* = 4.1 Hz, 1H), 7.66--7.59 (m, 1H), 7.33 (t, *J* = 7.3 Hz, 4H), 7.24 (dd, *J* = 21.8, 7.2 Hz, 6H), 7.18--7.10 (m, 2H), 5.76 (s, 1H). ^13^C NMR (101 MHz, CDCl~3~): δ 163.2, 149.5, 142.7, 136.4, 129.4, 128.4, 126.5, 123.8, 121.4, 59.4. HR-MS (FTMS^+^) \[M + H\]^+^ Calculated (C~18~H~15~NH): 246.1277. Found: 246.1277. The compound characterization is in agreement with that previously reported.^[@ref55]^

### 2-(Bis(4-(*tert*-butyl)phenyl)methyl)pyridine **L2** {#sec4.1.5}

A mixture of the **A2** (0.900 g, 2.41 mmol), aqueous 57% HI (2.70 mL), and HOAc (13.20 mL) was heated to 100 °C for 4 h. The resulting mixture was then cooled to 0 °C and basified to pH 9 with an aqueous NaOH solution (2 M). Ethyl acetate (100 mL) was added, and the mixture was washed successively with an aqueous NaHSO~3~ solution and brine. The combined organic layers were dried over MgSO~4~, and the solvent was evaporated. The residue was purified over silica (10% EtOAc in petroleum ether as the solvent). The desired fractions were combined and the solvent evaporated, yielding the title compound as oil (0.655 g, 1.83 mmol). Yield: 76%. R~f~: 0.33 (10% EtOAc in petroleum ether on silica). ^1^H NMR (400 MHz, CDCl~3~): δ 8.62--8.56 (m, 1H), 7.62--7.56 (m, 1H), 7.31 (s, 4H), 7.10 (s, 6H), 5.62 (s, 1H), 1.29 (s, 18H). ^13^C NMR (126 MHz, CDCl~3~): δ 163.8, 149.6, 149.2, 139.9, 136.5, 129.0, 125.4, 123.9, 121.4, 58.7, 34.5, 31.5. HR-MS (ASAP^+^) \[M + H\]^+^ Calculated (C~26~H~31~NH): 358.2535. Found: 358.2534.

### 2-(Bis(4-(trifluoromethyl)phenyl)methyl)pyridine **L3** {#sec4.1.6}

A mixture of **A3** (0.500 g, 1.26 mmol, 1 equiv) and PBr~3~ (25 mL) was vigorously stirred and heated and kept at 110 °C for 2 h. The mixture was then cooled to r.t. and was carefully poured onto ice, and aqueous NaOH (2 M) was added until the pH was neutral. The organic layer was dried over MgSO~4~, and the solvent was evaporated, leaving a residue which was dissolved in acetic acid (50 mL). Then, zinc dust (0.799 g, 12.60 mmol, 10 equiv) was added. The mixture was stirred at r.t. After 1 h, 20 mL of water was carefully added, and aqueous NaOH (2 M) was added until the pH was neutral. The organic layer was dried over MgSO~4~, and the solvent was evaporated, leaving a residue which was purified over silica (10% EtOAc in petroleum ether as the solvent). The desired fractions were combined, and the solvent was evaporated, leaving colorless oil (0.117 mg, 0.31 mmol). Yield: 24%. R~f~: 0.55 (20% EtOAc in petroleum ether on silica). ^1^H NMR (400 MHz, CDCl~3~): δ 8.63 (ddd, *J* = 4.9, 1.9, 0.9 Hz, 1H), 7.66 (td, *J* = 7.7, 1.9 Hz, 1H), 7.57 (d, *J* = 8.2 Hz, 4H), 7.30 (d, *J* = 8.1 Hz, 4H), 7.20 (ddd, *J* = 7.6, 4.8, 1.1 Hz, 1H), 7.10 (dt, *J* = 7.9, 1.1 Hz, 1H), 5.75 (s, 1H). ^13^C NMR (126 MHz, CDCl~3~): δ 161.4, 150.1, 146.0, 137.0, 129.8, 129.3, 125.7, 125.3, 124.0, 122.2, 58.9. ^19^F NMR (376 MHz, CDCl~3~): δ −62.50. HR-MS (FTMS^+^) \[M + H\]^+^ Calculated (C~20~H~13~F~6~NH): 382.1030. Found: 382.1023.

General Procedure for the One-Pot Protocol {#sec4.2}
------------------------------------------

A mixture of the corresponding ligand (1.2 equiv) and IrCl~3~·6H~2~O (1 equiv) in 2-ethoxyethanol (15 mL) and H~2~O (5 mL) was heated under stirring to 125 °C. After 19 h, 4,4′-di-*tert*-butyl-2,2′-bipyridine (1.5 equiv) was added, and heating was continued. After 6 h, the solvent was evaporated, leaving a solid, which was filtered over silica (1% MeOH in CH~2~Cl~2~). The desired fractions were combined, and the solvent was evaporated, leaving a solid which was washed with diethyl ether. After filtration, the desired complex was obtained as a solid.

### \[Ir(bnpy)(d*t*Bubpy)Cl\] (**1**) {#sec4.2.1}

The general one-pot protocol using 0.114 g (0.38 mmol) of IrCl~3~·6H~2~O was followed, and **1** was obtained as a red solid (0.127 g, 0.0.13 mmol). Yield: 45%. Mp: 320 °C (decomp.). ^1^H NMR (400 MHz, CD~2~Cl~2~): δ 8.75 (d, *J* = 5.8 Hz, 2H), 8.42 (d, *J* = 1.7 Hz, 2H), 7.70 (dd, *J* = 7.3, 1.4 Hz, 2H), 7.53 (d, *J* = 7.5 Hz, 1H), 7.49 (dd, *J* = 5.9, 1.9 Hz, 3H), 7.24 (dd, *J* = 7.1, 1.6 Hz, 2H), 7.19 (d, *J* = 5.9 Hz, 1H), 6.90 (dtd, *J* = 26.4, 7.3, 1.5 Hz, 4H), 6.45--6.39 (m, 1H), 5.28 (s, 1H), 1.50 (s, 18H). ^13^C NMR (126 MHz, CD~2~Cl~2~): δ 165.4, 162.6, 157.4, 151.8, 151.3, 143.9, 141.4, 138.7, 137.0, 125.8, 124.0, 123.8, 123.4, 122.7, 122.1, 120.8, 69.7, 35.9, 30.8. HR-MS (ASAP^+^) \[M--Cl\]^+^ Calculated (C~36~H~37~IrN~3~): 704.2618. Found: 704.2618. CHN Calcd for C~36~H~37~ClIrN~3~·3/2 H~2~O: C, 56.42; H, 5.26; N, 5.48. Found: C, 56.45; H, 5.24; N, 5.28.

### \[Ir(d*t*Bubnpy)(d*t*Bubpy)Cl\] **2** {#sec4.2.2}

The general one-pot protocol using 0.088 g (0.30 mmol) of IrCl~3~·6H~2~O was followed, and **2** was obtained as a red solid (0.129 g, 0.15 mmol). Yield: 51%. Mp: 331 °C (decomp.). ^1^H NMR (400 MHz, CD~2~Cl~2~): δ 8.79 (d, *J* = 5.9 Hz, 2H), 8.42 (d, *J* = 2.0 Hz, 2H), 7.80 (d, *J* = 2.1 Hz, 2H), 7.49--7.42 (m, 4H), 7.13 (d, *J* = 7.7 Hz, 3H), 6.89 (dd, *J* = 7.7, 2.1 Hz, 2H), 6.38 (ddd, *J* = 7.0, 5.9, 2.0 Hz, 1H), 5.22 (s, 1H), 1.51 (s, 18H), 1.32 (s, 18H). ^13^C NMR (126 MHz, CD~2~Cl~2~): δ 166.0, 162.6, 157.5, 151.7, 151.3, 147.8, 141.1, 140.4, 136.8, 135.9, 123.7, 123.6, 122.7, 122.4, 120.8, 118.8, 68.6, 35.9, 34.9, 32.1, 30.9. \[M--Cl\]^+^ Calculated (C~44~H~53~IrN~3~) 816.3869. Found: 816.3867. CHN Calcd for C~44~H~53~ClIrN~3~: C, 62.06; H, 6.27; N, 4.93. Found: C, 61.96; H, 6.31; N, 5.02.

### \[Ir(dtfmbnpy)(d*t*Bubpy)Cl\] **3** {#sec4.2.3}

The general one-pot protocol using 0.060 g (0.20 mmol) of IrCl~3~·6H~2~O was followed, and **3** was obtained as a yellow solid (0.096 g, 0.11 mmol). Yield: 55%. Mp: 324 °C (decomp.). ^1^H NMR (400 MHz, CD~2~Cl~2~): δ 8.59 (d, *J* = 5.8 Hz, 2H), 8.44 (d, *J* = 2.0 Hz, 2H), 7.98 (d, *J* = 2.0 Hz, 2H), 7.62--7.48 (m, 4H), 7.37 (d, *J* = 7.7 Hz, 2H), 7.20--7.15 (m, 3H), 6.50 (ddd, *J* = 7.5, 5.9, 1.7 Hz, 1H), 5.46 (s, 1H), 1.51 (s, 18H). ^13^C NMR (126 MHz, CD~2~Cl~2~): δ 163.5, 163.3, 157.3, 151.9, 151.1, 147.4, 142.2, 137.6, 134.7, 127.6, 126.7, 124.5, 124.3, 123.5, 123.4, 121.2, 119.4, 69.2, 36.0, 30.8. ^19^F NMR (376 MHz, CD~2~Cl~2~): δ −61.58. \[M--Cl\]^+^ Calculated (C~38~H~35~F~6~IrN~3~): 840.2364. Found: 840.2379. CHN Calcd for C~38~H~35~F~6~IrN~3~: C, 52.14; H, 4.03; N, 4.80. Found: C, 52.10; H, 4.16; N, 4.74.
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